Armata Pharmaceuticals Income Statement (2013-2018) | ARMP

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018
Revenue & cost
Revenue 0.02M0.31M0.00M-0.25M0.10M0.10M0.10M0.10M0.10M0.10M0.14M0.13M0.11M0.10M0.03M0.02M0.03M0.03M0.04M0.02M-0.28M-0.31M-0.34M
Operating items
Amortization - Intangibles 0.30M2.33M
Research & Development 0.64M3.60M1.12M1.11M1.01M1.89M1.79M1.11M0.97M1.08M0.73M1.22M1.98M1.24M0.04M5.55M1.49M1.13M1.09M2.29M1.92M1.98M
Selling, General & Administrative 0.71M2.84M1.22M1.22M1.63M1.96M1.70M1.56M1.40M1.62M1.84M1.85M2.64M2.45M1.78M1.54M1.90M2.78M1.61M1.29M0.56M0.51M0.81M
Other Operating Expenses 1.84M0.02M1.61M4.80M5.80M-0.83M-5.88M-4.05M-5.42M
Operating Expenses 1.35M6.44M2.34M2.33M2.64M3.85M5.33M2.70M2.37M2.69M2.57M3.07M4.62M3.69M3.44M11.89M3.39M9.71M0.78M2.38M2.84M2.43M2.79M
Operating Income -1.33M-6.12M-2.34M-2.59M-2.53M-3.75M-5.23M-2.60M-2.27M-2.59M-2.43M-2.94M-4.52M-3.59M-3.41M-11.86M-3.36M-9.69M-0.75M-2.37M-2.84M-2.43M-2.79M
EBIT -1.33M-6.12M-2.34M-2.59M-2.53M-3.75M-5.23M-2.60M-2.27M-2.59M-2.43M-2.94M-4.52M-3.59M-3.41M-11.86M-3.36M-9.69M-0.75M-2.37M-2.84M-2.43M-2.79M
Non-operating items
Interest & Investment Income 0.06M0.07M0.07M
Other Non Operating Income -0.31M-8.52M-46.41M3.04M-8.77M17.62M26.44M1.93M-12.23M13.36M7.87M0.64M1.41M-0.26M1.03M1.81M0.11M1.92M-0.04M0.01M-0.32M-0.34M2.46M
Non Operating Income -0.31M-8.52M-46.41M3.04M-8.77M17.62M26.44M1.93M-12.23M13.36M7.87M0.64M1.41M-0.26M1.03M1.81M0.11M1.92M-0.03M0.01M-0.32M-0.34M1.69M
Net income details
EBT -1.43M-6.25M-2.35M-2.59M-11.31M-3.75M-5.23M-2.60M-2.70M-2.59M-2.30M-2.94M-4.52M-3.85M-2.38M-10.06M-3.36M-7.76M-0.78M-2.35M-3.17M-2.77M-1.10M
Tax Provisions -0.07M-1.30M
Profit After Tax -1.65M-14.64M-48.75M0.46M-11.31M13.87M21.21M-0.66M-14.49M10.77M5.44M-2.23M-3.11M-3.85M-2.38M-9.50M-3.25M-6.46M-0.78M-2.35M-3.17M-2.77M-1.10M
Income from Continuing Operations -1.43M-6.25M-2.35M-2.59M-11.31M-3.75M-5.23M-2.60M-2.70M-2.59M-2.30M-2.87M-4.52M-3.85M-2.38M-10.06M-3.36M-6.46M-0.78M-2.35M-3.17M-2.77M-1.10M
Consolidated Net Income -1.43M-6.25M-2.35M-2.59M-11.31M-3.75M-5.23M-2.60M-2.70M-2.59M-2.30M-2.87M-4.52M-3.85M-2.38M-10.06M-3.36M-6.46M-0.78M-2.35M-3.17M-2.77M-1.10M
Income towards Parent Company -1.43M-6.25M-2.35M-2.59M-11.31M-3.75M-5.23M-2.60M-2.70M-2.59M-2.30M-2.87M-4.52M-3.85M-2.38M-10.06M-3.36M-6.46M-0.78M-2.35M-3.17M-2.77M-1.10M
Preferred Dividend Payments 0.10M0.29M0.23M0.31M0.32M0.32M0.33M0.34M1.83M7.16M0.95M1.73M0.13M
Net Income towards Common Stockholders -1.65M-14.75M-49.04M0.23M-11.62M9.39M14.49M-0.99M-14.83M8.94M-1.72M-3.18M-4.84M-6.35M-3.59M-9.50M-3.25M-8.04M-0.78M-2.33M-3.05M-1.63M-8.91M
Additional items
EPS (Basic) -0.03-0.16-0.490.00-3.182.563.87-0.27-3.491.27-0.30-0.59-8.22-7.26-3.23-9.66-1.94-1.21-0.09-0.04-0.68-0.60-0.24
EPS (Weighted Average and Diluted) -0.16-0.490.00-3.18-0.63-0.90-0.17-3.491.18-0.30-0.59-0.82-7.82-3.23-9.66-1.46-0.09-0.35-0.68-0.60-0.24
Shares Outstanding (Weighted Average) 66.91M90.65M99.16M101.20M182.54M3.67M3.74M3.75M4.25M5.67M5.81M5.41M0.59M0.87M1.11M0.98M1.68M5.35M8.87M6.39M13.30M4.65M4.65M
Shares Outstanding (Diluted Average) 90.65M99.16M101.20M5.93M5.88M5.89M4.25M7.55M5.81M5.41M5.88M0.88M1.11M0.98M5.52M8.87M6.57M4.65M4.65M
EBITDA -1.73M-12.65M-43.92M0.75M-12.03M15.39M19.30M-2.60M-2.27M-2.59M-2.43M-2.94M-4.52M-3.59M-3.41M-11.86M-3.36M-9.69M-0.75M-2.37M-3.16M-2.77M-1.10M
Interest Expenses 0.10M0.13M0.01M8.77M0.43M-0.13M0.23M0.33M0.00M0.28M0.31M0.34M
Tax Rate 2.48%16.77%